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Abstract
Background: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) were to
evaluate the effect and safety of local anesthetic infusion pump versus placebo for pain management following
total knee arthroplasty (TKA).
Methods: In September 2016, a systematic computer-based search was conducted in the Pubmed, ISI Web of
Knowledge, Embase, Cochrane Database of Systematic Reviews. Randomized controlled trials of patients prepared
for primary TKA that compared local anesthetic infusion pump versus placebo for pain management following TKA
were retrieved. The primary endpoint was the visual analogue scale (VAS) with rest or mobilization at 24, 48 and
72 h and morphine consumption at 24 and 48 h. The second outcomes are range of motion, length of hospital
stay (LOS) and complications (infection, deep venous thrombosis (DVT), prolonged drainage and postoperative
nausea and vomiting (PONV)).
Results: Seven clinical studies with 587 patients were included and for meta-analysis. Local anesthetic infusion
pump are associated with less pain scores with rest or mobilization at 24 and 48 h with significant difference.
However, the difference was likely no clinical significance. There were no significant difference between the LOS,
the occurrence of DVT, prolonged drainage and PONV. However, local anesthetic infusion pump may be associated
with more infection.
Conclusion: Based on the current meta-analysis, we found no evidence to support the routine use of local
anesthetic infusion pump in the management of acute pain following TKA. More RCTs are still need to identify the
pain control effects and optimal dose and speed of local anesthetic pain pump.
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Background
The number of primary total knee arthroplasty (TKA)
procedures will be reached at 3.48 million in 2030 in the
United States and the number will be as eight-fold to
the year of 2005 [1]. TKA was associated with moderate
to severe postoperative pain. It is reported that approxi-
mately 60% of patients have severe pain and 30% of patients
have moderate pain after TKA [2]. The pain has follow
specific characteristics: the occurrence in mobilization
is higher than in rest; and pain intensity always peaking
at 3 to 6 h after TKA and continuing for the following
72 h [3]. Achievement of pain relief after TKA is neces-
sary and early pain control after TKA can increasing
patients satisfaction and reducing the length of hospital
stay [4, 5]. Several effective modalities are available, but
each has its own drawbacks. These modalities including
oral opiates, femoral nerve block (FNB) and local infiltra-
tion anesthesia [6, 7]. FNB may weaken the quadriceps
strength and increase the occurrence of fall. Oral opiates
will increase the complications such as the postoperative
nausea and vomiting (PONV).
Local infiltration anesthesia (LIA) has been identified a
successful and easy way to management postoperative
pain, and promote early mobilization after TKA [8]. A
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meta-analysis indicated that LIA shows better pain control
than FNB, which is considered to be the gold standard
anesthesia method [9]. However, the anesthetic effects of
LIA disappears within the first 24 h, attempts have been
made to prolong the anesthetic effect using infusion pump
for continuous local infiltration anesthesia (CLIA) [10].
There have been controversies about the effects of CLIA
with infusion pump after TKA [11, 12]. Thus, we carried a
systematic review and meta-analysis to re-assess the effi-




Two reviewers independently retrieved randomized con-
trolled trials of CLIA for pain control in patients after
TKA from PubMed, EMBASE, and the Cochrane Library.
The search was last performed on August 23, 2016. There
was no language restriction. The keywords and Mesh
terms used in the search included “Arthroplasty, Replace-
ment, Knee”[Mesh], “total knee arthroplasty”, “total knee
replacement”, “TKA”, “TKR”, “Anesthesia, Local”[Mesh],
“local infiltration anesthesia”. We selected local infiltration
anesthesia for avoiding leave out relevant studies. The
Boolean operators “AND” and “OR” were used to connect
these terms. The bibliographies of all included studies and
other relevant publications, including systematic reviews
and meta-analyses, were traced to identify the missed rele-
vant reports. Based on the titles and abstracts, 2 reviewers
selected the potential eligible studies. And then the full
text of the remaining articles was examined for eligibility.
Inclusion and exclusion criteria
Inclusion criteria: Participants, patients with osteoarthritis
or rheumatoid arthritis who prepared for primary TKA.
Intervention and comparison-intervention group was con-
tinuous local infiltration anesthesia via infusion pump and
the comparison group was placebo alone; Outcomes-The
visual analogue scale (VAS) with rest or mobilization at
12, 24, 48 and 72 h. Study-Only randomized controlled
trials were included in this study. Exclusion criteria: Par-
ticipants, who underwent revision TKA; non-RCTs, com-
ments, incomplete data for meta-analysis and letters.
Data extraction and outcome measures
Two independent reviewers selected the eligible studies
and extracted the following data from the included pub-
lication: the first author, year of publication, geographical
location, number of patients, intervention and compari-
son, duration of the treatment, follow-up, patient char-
acteristics, and study type. We contacted the first or the
corresponding author for detailed study information.
Any discrepancies between the 2 reviewers were resolved
by an additional investigator.
The primary outcomes were the VAS with rest at 24,
48 and 72 h, VAS with mobilization at 24, 48 and 72 h
and total morphine consumption. The secondary outcomes
were range of motion (ROM) of knee at 6 month, length of
hospital stay (LOS), and the complications (infection, deep
venous thrombosis (DVT), prolonged drainage and postop-
erative nausea and vomiting (PONV)). We chose the lon-
gest time point to measure the range of motion of knee.
When standard deviations (SD) were not provided in a
study, standard error of the mean (SEM) was transferred
into SD. If necessary, the means, SD, or SEM were ex-
tracted from the available diagrams and tables by the
software of “GetData Graph Digitizer”.
Risk of bias assessment
The risk of bias tool was used to estimate the quality by
using Review Manager, version 5.3 (The Nordic Cochrane
Centre, The Cochrane Collaboration, Copenhagen, 2014).
The sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome assess-
ment, incomplete outcome data, selective outcome report-
ing, and other biases (baseline balance and fund) was
measured and the risk of bias results was exported from
Review Manager, version 5.3. Two authors independently
assessed the quality of the studies, and disagreements were
resolved via a discussion with a third author. And the level
of agreement between the 2 reviewers was assessed with
the Cohen kappa statistic and set the acceptable threshold
value as 0.61 [13, 14].
Statistical analysis
The meta-analysis was performed on the eligible data
using Stata12.0 (Stata Corp, College Station, TX). The
relative risk (RR) with 95% confidential intervals (CIs)
was calculated for the dichotomous outcomes, and the
mean difference (MD) with 95% CIs was calculated for
the continuous outcomes. The I2 statistic was used to
test the heterogeneity between studies. Heterogeneity
was considered statistically significant if the I2 value was
>50%. To assess the reliability of the results, a sensitivity
analysis was performed by sequentially removing indi-
vidual studies and recalculating the results. P < 0.05 was
considered statistically significant and reported as a 2-
sided test. Egger linear regression test and funnel plots
would be implemented to estimate the publication bias.
Results
Search results and quality assessment
The initial search yielded 213 citations, of which, 48 dupli-
cates were removed using Endnote software. After reading
the titles and abstracts, 49 studies were excluded accord-
ing to the inclusion criteria. Finally, 7 RCTs [10–18] with
587 TKAs were identified in our study (Fig. 1). The char-
acteristics of the included studies are presented in Table 1.
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Fig. 1 The flow diagram for the included studies
Table 1 The general characteristic for the included studies, 1 VAS with rest at 12 h, 2 VAS with rest at 24 h, 3 VAS with rest at 48 h,
4, VAS with rest at 72 h, 5, VAS with mobilization at 12 h, 6, VAS with mobilization at 24 h, 7, VAS with mobilization at 48 h, 8, VAS
with mobilization at 72 h; 9, length of hospital stay; 10, morphine consumption at 24 h; 11, morphine consumption at 48 h; 12, the











CLIA C CLIA C
Nechleba 2005 [15] 14 16 63.3 65 200 cc 0.25% bupivacaine at 4.16 cc 200 cc Saline 2 3 11 12 RCT 6 week
Reeves 2009 [16] 31 30 41 69 240 cc 0.2% ropivacaine or 0.375%
ropivacaine at 5 cc/h
240 cc Saline 2 3 6 7 8 11 RCT 2 day
Gomez-Cardero 2011 25 25 38 71 300 cc 0.2% ropivacaine at a speed
of 5 cc/h
300 cc Saline 12 RCT 1 month
Zhang 2011 [12] 27 26 47.2 67 199 cc 2 mg/ml ropivacaine plus
2 ml 2 mg/ml ketorolac at 4 cc/h
199 cc saline 1 2 3 5 6 7 9 10 11 12 14 RCT 3 month
Goyal 2013 [10] 75 75 45.3 63 300 cc 0.5% bupivacaine 300 cc Saline 6 7 8 9 10 11 12 RCT 6 week
Williams 2013 [11] 26 25 41.2 67 0.5% bupivacaine at 2 cc/h Saline 2, 3 9 13 9 10 14 RCT 1 y
Ali 2015 [18] 97 95 36.5 69 100 cc 7.5 mg/ml ropivacaine at 2 cc/h 100 cc Saline 2 3 4 7 10 11 12 13 RCT 3 m
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The included studies were published from the year of
2005 to 2015. The sample of patients ranged from14 to
97. The mean age of patients ranging from 63 to 71. And
the volume of pain pump ranging from 100 to 300 ml.
The delivery speed from 2 to 5 ml/h. Only one study did
not state the delivery speed [10].
The quality assessment results can be seen in Figs. 2
and 3. Only 1 study did not state the random sequence
generation [15]. The other studies are all give appropri-
ate random sequence generation. The allocation conceal-
ment are not clear in 2 studies [15, 16]. Blinding of
participants and outcome assessment are unclear in 1
study [15]. The other bias are all with low bias. The
agreement between the reviewers for risk of bias, based
on kappa statistic, was 0.90.
Results of the meta-analysis
VAS with rest at 24, 48 and 72 h
Five studies, including 384 patients, provided data for
the VAS with rest at 24 h. The CLIA group was associ-
ated with a significant decrease in the VAS with rest at
24 h compared with the controls (MD = −11.09, 95% CI:
−18.17–4.00, P = 0.002; I2 = 75.1%, Fig. 4). The data on
the VAS with rest at 48 h and at 72 h were available
from 5 studies and 2 studies respectively. There was no
significant difference between the VAS with rest at 48 h
(MD = −5.55, 95% CI: −16.30–5.20, P = 0.311; I2 = 91.5%,
Fig. 4) and 72 h (MD= 0.53, 95% CI: −5.65–6.72, P = 0.866;
I2 = 38.4%, Fig. 4) between CLIA group with control group.
Egger’s test was performed to test the publication bias be-
tween the included studies. Results indicated that there was
no publication bias between the studies (P = 1.000, Fig. 5).
VAS with mobilization at 24, 48 and 72 h
Three studies (n = 263) contributed to the analysis of
the VAS with mobilization at 24 h. The VAS with
mobilization at 24 h was significantly decreased in the
CLIA group compared with the controls (MD = −13.94,
95% CI: −17.31– −10.57, P = 0.000; I2 = 0.0%, Fig. 6).
The data on the VAS with mobilization at 48 h were
available in 3 studies, the pooled results indicated that
CLIA can reduce VAS with mobilization at 48 h for a
mean of 9.50 (95% CI: −15.20– −10.56, P = 0.001, Fig. 6).
There was no significant difference between the VAS
with mobilization at 72 h (MD= −1.33, 95% CI: −16.95–
14.30, P = 0.868; I2 = 86.9%, Fig. 6).
Fig. 2 The risk of bias graph
Fig. 3 The risk of bias summary
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Total morphine consumption
In 3 studies (n = 296), provided the data for the total
morphine consumption between the CLIA group with
controls. Pooled results indicated that there was no sig-
nificant difference between the morphine consumption
between CLIA group with controls (SMD = −0.64, 95%
CI: −0.88– −0.40, P = 0.000; I2 = 90.3%, Fig. 7).
ROM of knee at 6 month after TKA
Four studies with 324 patients reported the relevant data
of ROM of knee at 6 month after TKA. Pooled results
indicated that, compared with control group, CLIA can
increase the ROM of knee at 6 month after TKA (MD =
5.26, 95% CI: 3.63~6.89, P = 0.000, Fig. 8).
LOS
Three studies (n = 411) contributed to the analysis of
LOS. We observed similar LOS when comparing the
CLIA group with the control group (MD = 0.05, 95% CI:
−0.20~o.30, P = 0.086, Fig. 9).
Complications
Four common complications (infection, DVT, prolonged
drainage and PONV) were compared between the included
studies. Results indicated that there was no significant dif-
ference between the occurrence of DVT (RR = 1.01, 95% CI
:0.30~3.41, P = 0.987, Fig. 10), prolonged drainage (RR =
1.67, 95% CI :0.23~12.33, P = 0.617, Fig. 10) and the occur-
rence of PONV (RR = 1.27, 95% CI :0.77~2.12, P = 0.255,
Fig. 10). However CLIA increase the occurrence of infec-
tion (RR = 3.45, 95% CI :1.16~10.33, P = 0.027, Fig. 10).
Subgroup analysis
The results of VAS with rest has large heterogeneity
between the included studies. Subgroup analysis was
conducted according to the delivery speed (<2 cc/h or
>2 cc/h) and the type of anesthesia drug (ropivacaine
or bupivacaine). Pooled results indicated that local in-
filtration anesthesia with pain pump with a high speed
(>2 cc/h) associated with less VAS with rest at 24 and
48 h than the low speed (<2 cc/h). And the local
Fig. 4 Forest plot comparing VAS with rest at 24, 48 and 72 h
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Fig. 6 Forest plot comparing VAS with mobilization at 24, 48 and 72 h
Fig. 5 Egger’s test for publication bias for VAS with rest at 24 h
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Fig. 7 Forest plot comparing total morphine consumption between the two groups
Fig. 8 Forest plot comparing range of motion between the two groups
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infiltration with ropivacaine is better than bupivacaine
for reducing VAS with rest at 24 and 48 h (Table 2).
Discussion
This is the first systematic review and meta-analysis that
compared local anesthetic infusion pump versus placebo
for pain management following TKA. The pooled results
indicated that administration with local anesthetic infu-
sion pump can reduce pain intensity with mobilization
and morphine consumption. The pain control and mor-
phine consumption were likely of no clinical importance.
There was no significant difference between the CLIA
group versus placebo group in terms of LOS and com-
plications such as PONV, DVT and prolonged drainage.
However, the occurrence of infection in local anesthetic
infusion pump group is higher than in placebo group.
Though there was significant difference between pain
score at 24 h with rest or mobilization, the clinical ef-
fects was limited. Thus, more RCTs for comparing local
anesthetic infusion pump versus placebo after TKA are
still need to identify the clinical value for pain control
after TKA.
For this meta-analysis, we only included RCTs for
meta-analysis, the quality of the included studies are all
high and comparable. Only one study did not state the
random sequence generation and the rest studies are all
referenced the random sequence generation. All in-
cluded studies all showed comparable characteristic and
intent to treatment. The local infiltration drugs and drug
delivery speed were different with each other. However,
the half-time of all the local infiltration drugs were very
nearly the same. The half-lives of bupivacaine was 3.5 h
and ropivacaine was 2 to 6 h [19]. Thus, subgroup ana-
lysis was conducted to independent analysis the ropiva-
caine and bupivacaine for the VAS with rest at 24 and
48 h. Indirect comparison shown that the pain-sparing
effects was better in ropivacaine group than in bupivacaine
group. What’s more, the local infiltration anesthesia with a
high speed is better than low speed group.
Pain control after TKA is always associated with the
functional recovery and patients satisfaction [20]. An op-
tion that has gained popularity is peri-articular infiltration
anesthesia or intra-articular anesthesia with pain pump for
continuous infiltration. There is no consistent conclusion
about the efficacy and safety of local anesthetic infusion
pump for pain control after TKA [11, 12]. Williams et al.
[11] conducted a RCT and found that pain score and mor-
phine consumption are not significantly reduced when
adding 48 h of 0.5% bupivacaine infiltration with pain
pump. Ali et al. [18] also performed a RCT about CLIA
with placebo for pain control after TKA and found that
CLIA has no relevant clinical effect on VAS pain and does
Fig. 9 Forest plot comparing length of hospital stay between the two groups
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not affect LOS, morphine consumption but with a higher
risk of wound-healing complications: deep infections. In
this meta-analysis, the pain score was reduced 11.09 score
with rest at 24 h and 13.94 score at 24 h with mobilization.
This effect was likely of clinical importance. With time go-
ing on, the pain score was reduced 5.55 with rest at 48 h
and 9.50 with mobilization at 48 h. The VAS with
mobilization at 48 h was likely clinical importance. For
VAS with rest or mobilization at 72 h, there were no
clinical importance for these outcomes. Indeed, the at-
tempts that administration with pain pump for prolong
the analgesic effect still need for more studies to identify.
The development of portable elastomeric infusion pumps
can make the infusion of postoperative local anesthetic
more easily available. However, if the pain control was lim-
ited in the first 24 h after TKA. The local infiltration
anesthesia with long action bupivacaine can also reach the
same effects. The costs and the operating time will be
Table 2 The subgroup analysis for the VAS with rest or mobilization at 24 and 48 h
Outcome Studies Overall effects Heterogeneity
Effect estimate 95% CI P value I2 (%) P value
VAS with rest at 24 h
low speed 2 −5.91 −11.00, −0.82 0.000 0.0 0.579
high speed 3 −17.78 −21.54, −14.02 <0.001 9.9 0.330
ropivacaine 3 −15.00 −18.32, −11.68 0.000 80.7 0.006
bupivacaine 2 −6.74 −14.06, −0.59 0.072 38.2 0.203
VAS with rest at 48 h
low speed 2 −3.36 −8.11, 1.38 0.165 0.0 0.843
high speed 3 −17.79 −20.59, −14.98 0.000 56.5 0.100
ropivacaine 3 −15.22 −17.78, −12.66 0.000 91.5 0.000
bupivacaine 3 −4.82 −12.02, 2.38 0.189 0.0 0.614
Fig. 10 Forest plot comparing the complications between the two groups
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increased correspondingly. Zhang et al. [12] compared
single-injection versus CLIA for pain control after
TKA and found that CLIA provided prolonged super-
ior analgesia and was associated with more functional
recovery compared with single-injection local anesthesia.
Wu et al. [21] conducted a meta-analysis to compare local
anesthetic infusion pump for pain management following
open inguinal hernia repair and found local anesthetic in-
fusion pump was more efficacious for reducing postopera-
tive pain than a placebo. The patients with different
surgery type may suffer from variable pain intensity.
For morphine consumption, though CLIA can decrease
the morphine consumption, however, only 0.64 mg was
saved. The saving effects was found to be small of clinical
effects. Thus, the effects of CLIA for morphine-saving is
limited. For knee function, 4 studies with 324 patients per-
form range of motion of knee and pooled results indicated
that CLIA can increase the ROM of knee for a mean of
5.26°. A total of 324 patients analyzed the ROM of the
knee and thus further studies are needed to enhance the
strength of the evidence presented. As for the complica-
tions, local anesthetic infusion pump are associated with
more patients subjected to infection. Though the differ-
ence is statistically significant, the clinical significance
worth deep research.
Our study has several limitations. First, the studies
contain small samples, ranging from 14 to 75 patients
per group, which might detract from the statistical power
of the results. Second, several studies did not report the
details of the generation and concealment of the alloca-
tion, and displayed other bias risks, such as the undeter-
mined number of surgeons involved in the study. Finally,
several of our primary and secondary outcomes were vari-
ably reported, thus potentially limiting the inferences
based on our analysis.
Conclusions
In conclusion, the results of our meta-analysis revealed
that applying a local anesthetic infusion pump following
TKA reduced postoperative pain compared to the placebo
treatments during postoperative day 1 to day 2. However,
the findings were based on a small body of evidence in
which the methodological quality was not high. And the
difference seems to be small of clinical effects. Based on
the current evidence, we did not recommend routinely ad-
ministration with local anesthetic infusion pump. Further
research involving high quality RCTs might be warranted.
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